A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503624-83-00

Acronym

INCB 00928-104

Enrollment

Registered

2024-09-05

Start date

2021-08-16

Completion date

Unknown

Last updated

2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaemia associated with myelofibrosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026